Do Closed Suction Drains Affect the Complications Rate of Breast Reconstruction With Silicone Prosthesis?

Sponsor
Sheba Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00973544
Collaborator
(none)
100

Study Details

Study Description

Brief Summary

The purpose of this study is to describe the relations between closed suction drains placement in breast reconstructions procedures with silicone prothesis to the development of local wound complications (seroma, hematoma, infections).

Condition or Disease Intervention/Treatment Phase
  • Other: Cultures taken from the drain discharge

Detailed Description

Breast reconstruction with silicone prosthesis can be divided into two groups: immediate and late reconstructions. The complications rates reported in the literature are around 30% for delayed reconstructions and 50% for immediate reconstructions. The estimated surgical site infection rate is approximately 7% and seroma formation rate is approximately 1.2%.

In many of the procedures closed suction drains are left for fluid drainage, in order to reduce seroma formation. Still, the timing of drains' removal is controversial. Our aim in this study is to describe the relation between the placement of closed suction drains, the timing for their removal, and immediate post operative complications.

Patients that underwent breast reconstruction with silicone prosthesis and in which drains will be left in the surgical field would be randomly assigned into two groups: a control group, in which drains will be removed when the daily discharge will be below 20 cc for two consecutive days and the study group, in which drains will be removed on post operative day (POD) 10. All patients will receive the same antibiotic prophylaxis regimen. Cultures will be taken from fluid discharge POD 4,8,10 and 12. The incidence of local wound complications such as infection, seroma, hematoma and skin necrosis was record and analyzed.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Complications of Breast Reconstruction With Silicone Prosthesis in Relation to Closed Suction Drains
Study Start Date :
Sep 1, 2009

Arms and Interventions

Arm Intervention/Treatment
control

drains would be removed when daily discharge will be below 20 cc for 2 consecutive days

Other: Cultures taken from the drain discharge
Cultures will be taken from drain's fluids discharge in Post Operative Day 4,8,10,12. When drain is removed cultures of the drain tip are taken. Clinical signs of surgical signs infections will be observed.

study

drains will be removed on post operative day (POD) 10

Other: Cultures taken from the drain discharge
Cultures will be taken from drain's fluids discharge in Post Operative Day 4,8,10,12. When drain is removed cultures of the drain tip are taken. Clinical signs of surgical signs infections will be observed.

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients that underwent immediate or late breast reconstruction with silicone prosthesis (expanders/implants)and in which closed suction drains were left in the operating field according to the decision of the operating surgeon.

    • signature of informed consent form

    Exclusion Criteria:
    • age under 18

    • breast reconstruction without prosthesis

    • Breast reconstruction without the use of drains

    • Active infection during time of surgery in surgical site

    • Coagulation disease

    • Psychiatric illness

    • Immune disease

    • Lack of communication or language problems

    • Foreign residents, not Israeli citizens

    • Prisoners

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Sheba Medical Center

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00973544
    Other Study ID Numbers:
    • SHEBA -08-5530 -EW- CTIL
    First Posted:
    Sep 9, 2009
    Last Update Posted:
    Sep 9, 2009
    Last Verified:
    Sep 1, 2009

    Study Results

    No Results Posted as of Sep 9, 2009